Publicador de contenidos

Investigación

MENA Migrant Health

Transforming data collection and surveillance to drive migrant health research, care and policy

Duración
2022-2025
Coordinador
Ana Requena
Financiadores
Foundation “la Caixa”/ Mobility – Global Medicine and Health Research programme

 

Migrant populations often live in precarious conditions with limited access to health care. The lack of epidemiological data on the major health problems affecting these populations hinders adequate health services and policies. 

The MENA Migrant Health project aims to overcome this barrier by designing new tools for data collection and analysis, as well as developing community-based research and practice that will ensure the future and continuous improvement in migrant health prevention and care.

The project is developing the Migrant Health Country Profile tool (MHCP-t) that will inform healthcare practitioners and policymakers on how to effectively monitor and respond to migrants' health needs on multiple infections and other key diseases, as well as vaccination coverage. A prototype of MHCP-t will be initially tested in Morocco, Tunisia and Sudan, and later rolled-out in Algeria, Libya, Egypt and Yemen. 

The implementation of the MHCP-t will provide access to an unprecedented database as well as analysis tools on migrant health in the MENA region. Thus, strengthening data collection, facilitating cross-country comparisons and transforming service delivery and policy-making around migration and health. 

To deploy the MHCP-t tool in different countries of the MENA region, the consortium will collaborate with local and international organizations that aim to improve the health of migrants in this region while holding approaches as different as research, management as well as health and social care, or the creation of more effective and equitable health policies. 

 

Total Funding

€1,499,996

Nuestro equipo

Principal investigator

ISGlobal team

Otros proyectos

Ver proyectos pasados

NHEPACHA

Nuevas Herramientas para el Diagnóstico y la Evaluación del Paciente con Enfermedad de Chagas

Estudio inmunológico de la vacuna RTS,S

Estudio de correlatos de protección frente a la malaria después de la vacunación con RTS,S/AS01E: Una evaluación inmunológica exhaustiva en el ensayo clínico de Fase III, doble ciego, aleatorizado, multicéntrico con un grupo control

Euroleish.net

Control of Leishmaniasis. From bench to bedside and community

GREPIMER

Grup de recerca en patología importada i malaties emergents i re-emergents

TESEO

Nuevos regímenes de quimioterapia y biomarcadores para la enfermedad de Chagas

ASINTMAL

Unravelling Disease Tolerance and Host Resistance in Afebrile 'P. falciparum' Infections: a Prospective Study in Mozambican Adults

ADAM

Administración masiva y focal de fármacos antimaláricos para avanzar hacia la eliminación de la malaria en Mozambique: acelerando la implementación de programas y políticas

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

Science4Pandemics

Citizens engagement digital platform for collective intelligence in pandemics

HIDDENVIVAX

Novel organ-on-a-chip technology to study extracellular vesicles-mediated cryptic infections in Plasmodium vivax malaria

EpiGen

Building Scalable Pathogen Genomic Epidemiology in Ethiopia

MalTransc

Transcriptional regulation of adaptation and developmental decisions in malaria parasites: from epigenetic variation to directed transcriptional responses

BOHEMIA

Broad One Health Endectocide-based Malaria Intervention in Africa

RESPONSE

Mechanisms of the transcriptional responses to changes in the environment in the malaria parasite Plasmodium falciparum

VivaxEVTalk

Extracellular Vesicles as Intercellular Communicators and Biomarkers of Cryptic Erythrocytic Infections in Plasmodium vivax malaria

VaMonoS

Unravelling the heterogoneity and function of monocytes in vaccination and immunity to malaria

CLIMSOCTRYPBOL

Insight on climate and social participatory research for integral management of vectorborne zoonosis caused by Trypanosoma cruzi and Leishmania spp. in the Bolivian Gran Chaco.

SexMal

Social affairs and sex in P. falciparum: implications for malaria elimination

MESA

La Alianza Científica para la Erradicación de la Malaria (MESA) tiene como objetivo avanzar en la ciencia de la erradicación de la malaria.

GenMoz

P. falciparum genomic intelligence in Mozambique

SMART

Identifying Severe Malaria with a new Aptamer-based Rapid diagnostic Test